Alexander I. Bondarenko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alexander I. Bondarenko has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Olga Panasiuk
2 shared publicationsAndras T Deak
Institute of Molecular Biology and Biochemistry Center of Molecular Medicine Medical University of Graz Graz Austria
1 shared publicationKonstantin Drachuk
Circulatory Physiology Department, A. A. Bogomoletz Institute of Physiology National Academy of Sciences (NAS) of Ukraine Kiev Ukraine
1 shared publication- Roland Malli
Gottfried Schatz Research Center, Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria
1 shared publication Vadim Sagach
Circulatory Physiology Department, A. A. Bogomoletz Institute of Physiology National Academy of Sciences (NAS) of Ukraine Kiev Ukraine
1 shared publication- Wolfgang F. Graier
Gottfried Schatz Research Center, Medical University of Graz, Graz, Austria
1 shared publication
Latest Publications
- 1 January 2015
- Published by Insight Knowledge in Pharmacologia
- Vol. 6 (1) , 31-37
Membrane Cholesterol Determines the Stimulatory Effect of Omega-3 PUFA on BK Channel Activity
- 1 January 2015
- Published by Insight Knowledge in Pharmacologia
- Vol. 6 (1) , 31-37
Membrane Cholesterol Determines the Stimulatory Effect of Omega-3 PUFA on BK Channel Activity
- Open Access
- 20 March 2013
- Published by Wiley in British Journal of Pharmacology
- Vol. 169 (4) , 933-948
N‐arachidonoyl glycine suppresses Na+/Ca2+ exchanger‐mediated Ca2+ entry into endothelial cells and activates BKCa channels independently of GPCRs
Background and Purpose: N‐arachidonoyl glycine (NAGly) is a lipoamino acid with vasorelaxant properties. We aimed to explore the mechanisms of NAGly's action on unstimulated and agonist‐stimulated endothelial cells.Experimental Approach: The effects of NAGly on endothelial electrical signalling were studied in combination with vascular reactivity.Key Results: In EA.hy926 cells, the sustained hyperpolarization to histamine was inhibited by the non‐selective Na+ / Ca2+ exchanger (NCX) inhibitor bepridil and by an inhibitor of reversed mode NCX, KB‐R7943. In cells dialysed with Cs+ ‐based Na+ ‐containing solution, the outwardly rectifying current with typical characteristics of NCX was augmented following histamine exposure, further increased upon external Na+ withdrawal and inhibited by bepridil. NAGly (0.3–30 μM) suppressed NCX currents in a URB597‐ and guanosine 5′‐O‐(2‐thiodiphosphate) (GDPβS)‐insensitive manner, [ Ca2+ ]i elevation evoked by Na+ removal and the hyperpolarization to histamine. In rat aorta, NAGly opposed the endothelial hyperpolarization and relaxation response to ACh. In unstimulated EA.hy926 cells, NAGly potentiated the whole‐cell current attributable to large‐conductance Ca2+ ‐activated K+ (BKCa) channels in a GDPβS‐insensitive, paxilline‐sensitive manner and produced a sustained hyperpolarization. In cell‐free inside‐out patches, NAGly stimulated single BKCa channel activity.Conclusion and Implications: Our data showed that NCX is a Ca2+ entry pathway in endothelial cells and that NAGly is a potent G‐protein‐independent modulator of endothelial electrical signalling and has a dual effect on endothelial electrical responses. In agonist pre‐stimulated cells, NAGly opposes hyperpolarization and relaxation via inhibition of NCX‐mediated Ca2+ entry, while in unstimulated cells, it promotes hyperpolarization via receptor‐independent activation of BKCa channels.
- 20 March 2013
- Published by Wiley in British Journal of Pharmacology
- Vol. 169 (4) , 933-948
Open AccessN‐arachidonoyl glycine suppresses Na+/Ca2+ exchanger‐mediated Ca2+ entry into endothelial cells and activates BKCa channels independently of GPCRs
Background and Purpose: N‐arachidonoyl glycine (NAGly) is a lipoamino acid with vasorelaxant properties. We aimed to explore the mechanisms of NAGly's action on unstimulated and agonist‐stimulated endothelial cells.Experimental Approach: The effects of NAGly on endothelial electrical signalling were studied in combination with vascular reactivity.Key Results: In EA.hy926 cells, the sustained hyperpolarization to histamine was inhibited by the non‐selective Na+ / Ca2+ exchanger (NCX) inhibitor bepridil and by an inhibitor of reversed mode NCX, KB‐R7943. In cells dialysed with Cs+ ‐based Na+ ‐containing solution, the outwardly rectifying current with typical characteristics of NCX was augmented following histamine exposure, further increased upon external Na+ withdrawal and inhibited by bepridil. NAGly (0.3–30 μM) suppressed NCX currents in a URB597‐ and guanosine 5′‐O‐(2‐thiodiphosphate) (GDPβS)‐insensitive manner, [ Ca2+ ]i elevation evoked by Na+ removal and the hyperpolarization to histamine. In rat aorta, NAGly opposed the endothelial hyperpolarization and relaxation response to ACh. In unstimulated EA.hy926 cells, NAGly potentiated the whole‐cell current attributable to large‐conductance Ca2+ ‐activated K+ (BKCa) channels in a GDPβS‐insensitive, paxilline‐sensitive manner and produced a sustained hyperpolarization. In cell‐free inside‐out patches, NAGly stimulated single BKCa channel activity.Conclusion and Implications: Our data showed that NCX is a Ca2+ entry pathway in endothelial cells and that NAGly is a potent G‐protein‐independent modulator of endothelial electrical signalling and has a dual effect on endothelial electrical responses. In agonist pre‐stimulated cells, NAGly opposes hyperpolarization and relaxation via inhibition of NCX‐mediated Ca2+ entry, while in unstimulated cells, it promotes hyperpolarization via receptor‐independent activation of BKCa channels.